Today's Range
$31.90 - $34.79
52-Week Range
$28.58 - $61.69
Market Cap

About Compass Pathways (NASDAQ:CMPS)


COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.

Show more

CMPS Stock Price

Statistics Highlights (NASDAQ:CMPS)

Shares Outstanding 41.73M Beta -
Public Float 25.64M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 4.32% Ex-Dividend Date
Held by Institutions 18.85% IPO Date Sep 18, 2020

CMPS Financial Summary

Dec 20 Dec 19 Dec 18
Revenue $0.00 $0.00 $0.00
EBITDA $-35.33M $-21.12M $-12.48M
Net Income $-60.33M $-19.61M $-13.22M
Total Assets $203.46M $32.39M $26.39M
Total Cash $190.33M $24.97M $22.91M
Total Debt $ $21.09M $
Sep 21 Jun 21 Mar 21
Revenue $0.00 $0.00 $0.00
EBITDA $-19.10M $-16.38M $-12.01M
Net Income $-15.85M $-17.53M $-12.71M
Total Assets $314.74M $335.16M $196.14M
Total Cash $293.96M $316.33M $179.52M
Total Debt $ $ $

(NASDAQ:CMPS) Stock Price FAQs

What is today's stock price of Compass Pathways (NASDAQ:CMPS)?

  • The current stock price of Compass Pathways (NASDAQ:CMPS) is $32.00.
  • Today CMPS stock price opened at $34.79 after previous close of $33.20.
  • During the day, Compass Pathways stock quote has varied from a low of $31.90 to a high of $34.79.

What is Compass Pathways's 52-week change?

  • CMPS 52-week high stock quote is $61.69, which is 92.80% above the current share price.
  • The Compass Pathways (NASDAQ:CMPS) 52-week low stock price is $28.58, which is 10.70% below the current share price.

Is Compass Pathways a buy?

  • According to 5 analysts, the current consensus recommendation for Compass Pathways stock is "Strong Buy" at an average rating score of 4.80 (out of 5).
  • There are currently 4 "Strong Buy", 1 "Buy", 0 "Hold", 0 "Sell", and 0 "Strong Sell" analysts recommendations for the CMPS stock.
  • The 12 month average price target forecast for CMPS stock is $65.00, representing a 103.10% increase from the current CMPS stock price of $32.00.

Compass Pathways (NASDAQ:CMPS) FAQ

How Much is Compass pathways Worth?

Compass pathways's worth today based on market capitalisation is $1.37B

How much money does Compass pathways make?

Last quarter (ended on September 30 ,2021) Compass pathways generated a net income of $-15.85M, representing a 5.33% increase compared to the same quarter a year before (ended on September 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Compass pathways generated a net income of $-60.33M, representing a 207.64% increase compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Compass pathways's “Financials” Section

How much dividend does Compass pathways Pay?

The current annualized dividend payout for CMPS stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Compass pathways's "Dividend" Section

What were Compass pathways’s last Earnings results?

For the last quarterly earnings period (ended on September 30, 2021) CMPS reported $-0.38 EPS for the quarter, beating the average analysts’ forecasts of $-0.47 EPS by $0.09 (19.93%).
View More Details on Compass pathways's 'Earnings' Section

What is Compass pathways’s Price to Earning (PE) ratio?

CMPS stock also has a Price to Sales (P/S) ratio of 0.00.

What is the Compass pathways's ticker?

Compass pathways trades on the NASDAQ stock market in USA under the ticker symbol "CMPS". Compass pathways’s stock symbol can also be displayed as "NASDAQ:CMPS".

When did CMPS go public?

Compass pathways completed its initial public offering (IPO) on September 18 ,2020.

Who are the owners of Compass pathways?

Compass pathways (NASDAQ:CMPS) is owned by 18.84% institutional shareholders and by 4.32% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "Avidity Partners Management LP", "Logos Global Management LP" and "Victory Capital Management Inc.", representing 6.35% of Compass pathways’s total shares outstanding.
Explore More Details on Compass pathways's “Ownership” Section

Who are the key executives of Compass pathways (CMPS)?

Compass pathways's key executive team includes the following managers:

  • Mr. George Jay Goldsmith, Co-Founder, Chairman & CEO (1954)
  • Mr. Lars Christian Wilde, Co-Founder, Pres & Chief Bus. Officer (1986)
  • Dr. Ekaterina Malievskaia M.D., Co-Founder, Chief Innovation Officer & Exec. Director (1967)
  • Mr. Piers John Morgan ACA, MA, Chief Financial Officer (1966)
  • Mr. Nathan Poulsen J.D., Gen. Counsel & Chief Legal Officer (1979)
  • Mr. Stephen D. Schultz, Sr. VP of Investor Relations (NA)
  • Ms. Tracy Cheung, Chief Communications Officer (NA)
  • Mr. Marco Mohwinckel, Chief Commercial Officer (NA)
  • Mr. Trevor Mill, Chief Devel. Officer (NA)
  • Dr. Greg Ryslik Ph.D., Sr. VP of Data Science, Machine Learning & Digital Health Research (NA)

What is Compass pathways’s Sector & Industry Classification?

Compass pathways (NASDAQ:CMPS) is classified under the "Healthcare" sector and under the "Medical Care Facilities" industry.

How many employees work for Compass pathways?

Currently the number of employees working for Compass pathways is 61.

Where are Compass pathways's Headquarters?

Compass pathways (NASDAQ:CMPS) is headquartered in United Kingdom.

What are Compass pathways's Address and Phone Number?

Compass pathways’s mailing address is 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT.
The company’s phone number is 44 64 6905 3974.

What is the official website for Compass pathways?

Compass pathways’s official website is